The Midas List Formula: How The World’s Top Venture Capitalists Are Ranked

Forbes and TrueBridge outline the 2026 Midas List methodology, which ranks the top 100 venture investors using verified exits, acquisitions and private valuations. The framework gives greater weight to recent investments and requires qualifying outcomes of at least $200 million for public exits or acquisitions, or $400 million in private valuations; the Seed List thresholds are $50 million and $100 million, respectively. AI now accounts for nearly two-thirds of total venture deal value, increasing the influence of investors in companies such as SpaceX, Anthropic and OpenAI as older wins age out of the scoring window.

Analysis

The investable implication is not the list itself but the signaling regime it reveals: capital is being re-priced around a narrower set of AI platform winners, and that feedback loop tends to extend private-market dispersion before it shows up in public comps. That favors investors with exposure to scarce frontier-model infrastructure and hurts “me-too” software and late-stage growth managers whose portfolios depend on broad multiple expansion rather than asset-level scarcity. The second-order effect is a higher bar for non-AI exits, which can suppress M&A currency for public software names over the next 12-18 months.

For public-market positioning, the aging-out of older, iconic winners is a reminder that backward-looking performance marks are a weak hedge against current portfolio concentration. The more important signal is that private AI valuation leadership can leak into public-market comparables through secondary demand, employee liquidity, and crossover ownership, creating a quasi-index effect around the best-capitalized AI ecosystems. That dynamic is supportive for the highest-quality infrastructure and model-adjacent names, but it also increases the risk of crowded positioning and abrupt de-rating if financing terms tighten.

The contrarian read is that concentration may be peaking rather than broadening. When a small number of companies dominate allocation, incremental upside can compress because late entrants pay for momentum while the real option value shifts to adjacent picks-and-shovels. If IPO windows remain shut, many venture marks will be pinned to private rounds, which can sustain optics but delay realized returns; that usually sets up a sharp reset once public comps stop validating private pricing. The biggest reversal risk is a 10-20% reset in AI private valuations, which would cascade quickly through crossover funds, late-stage growth funds, and secondary liquidity plans.

Key Decisions for Investors

• Go long MSFT / NVDA on a 3-6 month horizon as the cleanest public proxy for frontier-AI capital concentration; use call spreads rather than outright stock to limit premium decay if the crowding trade pauses.
• Short a basket of high-multiple, non-AI public software names over the next 1-2 quarters (e.g., CRM, DOCU, ZEN) versus long QQQ as a relative-value hedge against valuation gravity migrating toward AI winners.
• Maintain/enter a long position in TSM with a 6-12 month view; if AI capex remains concentrated, advanced-node and packaging demand should stay resilient even if software monetization lags.
• Pair long CRWD / short a basket of legacy IT services or generic SaaS over 2-3 quarters; security and workflow vendors with direct AI exposure should outgrow the median at a lower earnings-risk profile.
• For more aggressive expression, buy 6-9 month put spreads on a late-stage venture/growth proxy such as ARKK as a hedge against a private-market mark reset if AI secondary and crossover demand cools.